Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rockwell Medical (RMTI) Accumulated Depreciation & Amortization (2016 - 2026)

Rockwell Medical filings provide 15 years of Accumulated Depreciation & Amortization readings, the most recent being $2.2 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 0.55% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 0.55% increase, with the full-year FY2025 number at $2.2 million, up 0.55% from a year prior.
  • Accumulated Depreciation & Amortization hit $2.2 million in Q4 2025 for Rockwell Medical, up from $1.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.2 million in Q4 2025 to a low of $138000.0 in Q1 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $560500.0 (2022), compared with a mean of $848400.0.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 31.68% in 2022 and later soared 240.62% in 2024.
  • Rockwell Medical's Accumulated Depreciation & Amortization stood at $668000.0 in 2021, then fell by 13.77% to $576000.0 in 2022, then skyrocketed by 150.69% to $1.4 million in 2023, then skyrocketed by 50.97% to $2.2 million in 2024, then grew by 0.55% to $2.2 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $2.2 million (Q4 2025), $1.6 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.